NCT01732913 · Interventional trial
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Overall registry status Terminated
Phase 3
Conditions Indolent Non-Hodgkin's Lymphomas
Delaware Valley sites
- Perelman Center for Advanced Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory